According to Tereshkin et al., the alterations in the levels of immunoreactive forms of GDH in the brains of patients with schizophrenia is one of the causes of impaired glutamate metabolism in the brain and an important aspect of the pathogenesis of schizophrenia [209]. This evidence concerns the gene GLUD1 and schizophrenia.